Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2026-03-04 @ 12:17 AM
Study NCT ID:
NCT02292550
Status:
COMPLETED
Last Update Posted:
2020-12-17
First Post:
2014-11-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non-small Cell Lung Cancer | View |